What can pharmaceutical companies do to help Chinese medicine "go global"?

Recently, at the press conference to promote the development of traditional Chinese medicine Zhuangyao medicine inheritance and innovation, the relevant person in charge stated that Guangxi is working hard to promote the inheritance and innovation of traditional Chinese medicine Zhuangyao medicine.
The special international cooperation project of Yao Medicine has formed an open cooperation pattern in the field of Chinese medicine, mainly in ASEAN countries and Hong Kong, Macao and Taiwan regions, covering more than 40 countries and regions
.
It is understood that in recent years, under the influence of the epidemic, the Chinese medicine industry has been paid more and more attention
.
In order to further promote the development of Chinese medicine, all parts of the country are stepping up to formulate a blueprint for the development of the Chinese medicine industry in the future
.
Among them, it is worth noting that accelerating the promotion of Chinese medicine going out is the key content of the development plan of Chinese medicine in many places including Guangxi
.
Earlier, the "Guangdong-Hong Kong-Macao Greater Bay Area Construction Plan for Traditional Chinese Medicine (2021-2025)" jointly issued by the State Administration of Traditional Chinese Medicine, the Office of the Leading Group for the Construction of the Guangdong-Hong Kong-Macao Greater Bay Area and the People’s Government of Guangdong Province also clearly stated that We will build a system and mechanism for Guangdong, Hong Kong, and Macao Chinese medicine to discuss, jointly build and share, accelerate the formation of a new pattern of Chinese medicine highland construction, create a medical highland, innovation highland, talent highland, and industrial highland in the Greater Bay Area, and further promote the high-quality development of Chinese medicine to help " The construction of the Belt and Road Initiative further promotes the internationalization of Chinese medicine
.
At present, from an overall point of view, with the help of policies, the pace of China's traditional Chinese medicine going out has begun to accelerate
.
According to statistics, in 2020, relevant domestic and foreign institutions in the TCM service trade statistics pilot have served a total of 2.
121 million person-times with revenue of 570 million yuan; of which, overseas revenue will exceed 60%
.
In addition to policy support, what kind of assistance can Chinese medicine companies, which are closely related to the development of the Chinese medicine industry, provide for their international development? Industry analysts believe that the influence of Chinese medicine in domestic and foreign markets has been increasing in recent years, laying a foundation for the promotion of Chinese medicine culture and expanding the Chinese medicine market, but the overall influence is not broad enough
.
Therefore, Chinese medicine companies still need to actively participate in and lead the formulation of relevant ISO international standards, strive for the legal status of Chinese medicine, and constantly defend China's right to speak in the international Chinese medicine market.

.
At the same time, Chinese medicine companies must also speed up going overseas, break through the technical barriers set by Chinese medicine standards, and actively promote industry-university-research cooperation, so as to provide more convincing data support for Chinese medicine companies to go overseas
.
Secondly, in the production of traditional Chinese medicine, it is very important to ensure the quality of the medicine
.
Therefore, if pharmaceutical companies want to better promote the development of Chinese medicine overseas, they must better ensure the safety of medicines
.
In this context, pharmaceutical companies can continue to promote the development of the Chinese medicine industry in a high-quality direction through technological innovation, the development of modern Chinese medicine scientific research and industrial production technology
.
It is reported that at present, some companies have carried out dosage form reforms while inheriting traditional Chinese medicine decoctions, digitally characterizing traditional experience, and processing them through modern industrialized equipment.
While maintaining the taste and efficacy of traditional Chinese medicine decoctions, it is also to a large extent It is convenient for patients to take
.
In addition, pharmaceutical companies can also promote Chinese medicine to go global by cultivating comprehensive talents
.
The analysis believes that the "going global" of Chinese medicine covers multiple industries such as medical care, education, culture, industry, equipment, and services.
It is necessary to build compound industrial talents in order to build a solid foundation for the overseas development of the Chinese medicine industry
.
Therefore, pharmaceutical companies can focus on cultivating innovative and comprehensive industrial talents to provide more solid and reliable talent support for Chinese medicine to "go global
.
"